Veru to present at three upcoming healthcare investment conferences

Miami, sept. 08, 2021 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, today announced that the company will present at the following upcoming healthcare investor conferences.

VERU Ratings Summary

VERU Quant Ranking